Searched for
ALEXION PHARMACEUTICALS
AstraZeneca profits fall, Covid vaccine sales slideNet profit slumped 64 percent to $746 million compared with the first six months of last year, AstraZeneca said in a statement. Operating e...- AstraZeneca sees $4B in COVID vaccine sales as revenue soarsAstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time. The c...
- AstraZeneca working on vaccine to prevent and cure Covid: MD Gagandeep SinghAnglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long...
- Wall Street ends down as Delta variant drives fearsAmazon and Apple fell more than 1%. Nvidia lost 4.2%, and the three companies contributed more than any others to the S&P 500 and Nasdaq's ...
- Moderna to join S&P 500, shares jump after hoursModerna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevati...
- AstraZeneca runs into 'meaningful' investor revolt over payAt an annual meeting of shareholders, 60.19% of votes were cast by shareholders in favour of approving Soriot's pay proposal, which takes h...
- Covid vaccine: Why is AstraZeneca making so many unforced errors?The has been communication of scientific results. November data from trials in the U.K. and Brazil generated confusion over efficacy. This ...
- AstraZeneca's Pascal Soriot: Know the man behind the Covid vaccineThe development of the vaccine with scientists at Oxford University -- and their decision to make it available at cost -- has made the Angl...
- S&P 500 ends down, Walt Disney weighsU.S. officials began to administer the vaccine developed by Pfizer and its German partner BioNTech on Monday following emergency-use approv...
- Ahead of Market: 12 things that will decide stock action on TuesdayGaurav Ratnaparkhi of Sharekhan by BNP Paribas said, though the upside momentum has weakened in the last few sessions, the bulls are managi...
- AstraZeneca shares sink 8% after $39 billion Alexion buyoutChief Executive Officer Pascal Soriot had told reporters on Saturday that the deal, a bet on rare-disease and immunology drugs, was the res...
- European shares cheer Brexit trade talks extension; AstraZeneca dropsWith banks in the lead, Europe's benchmark STOXX 600 index rose 0.7% after breaking a five-week winning streak to end 1% lower last week.
- AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
- India to unveil new drug policy: OfficialsA team of Indian officials led by G N Singh, Drug Controller General of India, said a set of new procedures to facilitate clinical trials a...
- Five Indian firms, including Hindustan Unilever and TCS, among Forbes' most innovative companiesFive Indian companies, including Hindustan Unilever and Tata Consultancy Services, are among Forbes' list of the world's 100 most innovativ...
- Larsen & Toubro, Hindustan Unilever, Infosys, TCS, Sun Pharma on world's 50 most innovative firms5 Indian cos - L&T, HUL, Infosys, TCS & Sun Pharma - have made to a list of the world's 50 most innovative firms, with the engineering gian...
Load More
